Jason M. Meggs - Jul 6, 2021 Form 4 Insider Report for Syneos Health, Inc. (SYNH)

Role
Chief Financial Officer
Signature
/s/ Sara Epstein, Attorney-in-Fact
Stock symbol
SYNH
Transactions as of
Jul 6, 2021
Transactions value $
-$29,154
Form type
4
Date filed
7/7/2021, 05:08 PM
Previous filing
Jul 2, 2021
Next filing
Sep 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SYNH Class A Common Stock Options Exercise $1.73K +40 +0.07% $43.16 60.7K Jul 6, 2021 Direct F1
transaction SYNH Class A Common Stock Sale -$3.6K -40 -0.07% $90.00 60.7K Jul 6, 2021 Direct F1
transaction SYNH Class A Common Stock Options Exercise $28.5K +620 +1.02% $46.00 61.3K Jul 6, 2021 Direct F1
transaction SYNH Class A Common Stock Sale -$55.8K -620 -1.01% $90.00 60.7K Jul 6, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SYNH Stock Option (Right to Buy Class A Common Stock) Options Exercise $0 -620 -100% $0.00* 0 Jul 6, 2021 Class A Common Stock 620 $46.00 Direct F2
transaction SYNH Stock Option (Right to Buy Class A Common Stock) Options Exercise $0 -40 -100% $0.00* 0 Jul 6, 2021 Class A Common Stock 40 $43.16 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2021.
F2 The shares subject to this option vested in four approximately equal annual installments on November 1, 2017; November 1, 2018; November 1, 2019; and November 1, 2020.
F3 The shares subject to this option vested in four approximately equal annual installments on July 29, 2016; July 29, 2017; July 29, 2018; and July 29, 2019.